Mutant ROS expression in human cancer

Details for Australian Patent Application No. 2010213578 (hide)

Owner Cell Signaling Technology, Inc.

Inventors Gu, Ting-lei; Tucker, Meghan Ann; Haack, Herbert; Crosby, Katherine Eleanor; Rimkunas, Victoria McGuinness

Agent Spruson & Ferguson

Pub. Number AU-A-2010213578

PCT Pub. Number WO2010/093928

Priority 61/207,484 12.02.09 US

Filing date 12 February 2010

Wipo publication date 19 August 2010

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/093928 Priority application(s): WO2010/093928

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010213580-Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylp henyl)methanol

2010213575-Peripheral administration of proteins including TGF-beta superfamily members for systemic treatment of disorders and disease